EdgeNewswire

SS Innovations International (NASDAQ: SSII) Announces First Dual-Console, Five-Arm Robotic Beating-Heart Bypass Surgery

  • 2 min read
  • SS Innovations NASDAQ: SSII

SS Innovations International (NASDAQ: SSII) announced the successful completion of what it describes as the world’s first dual-console, beating-heart totally endoscopic coronary artery bypass (“TECAB”) surgery utilizing all five arms of its SSi Mantra surgical robotic system. The procedure was performed at Medanta – The Medicity Hospital in Gurugram, India, by Dr. Nitin Kumar Rajput of Medanta Hospital and Dr. Lalit Malik of Manipal Hospital, Jaipur, under the guidance of SS Innovations Chairman and CEO Dr. Sudhir Srivastava. The surgeons operated simultaneously using separate control consoles, with all five robotic arms working in synchronization while a stabilization system steadied the surgical area.

The minimally invasive procedure enabled surgeons to perform coronary artery bypass surgery through small incisions without opening the chest or using a heart-lung machine, allowing the patient’s heart to continue beating throughout the operation. According to the company, the successful integration of dual-console control and five robotic arms represents an advancement in robotic cardiac surgery. Medanta Hospital Chairman and Managing Director Dr. Naresh Trehan reported that the patient was doing extremely well following the procedure, while SS Innovations highlighted the achievement as part of its mission to make advanced robotic surgery more affordable and accessible worldwide.

At a glance

Company
SS Innovations International
Ticker
NASDAQ: SSII
Location
Gurugram, India

Key figures

Robotic arms used
five arms
Operating consoles
dual-console

People

  • Dr. Nitin Kumar RajputSurgeon, Medanta Hospital
  • Dr. Lalit MalikSurgeon, Manipal Hospital, Jaipur
  • Dr. Sudhir SrivastavaChairman and CEO of SS Innovations
  • Dr. Naresh TrehanChairman and Managing Director of Medanta Hospital

Products and programs

  • SSi Mantra surgical robotic system
  • SSi Mudra surgical instruments

To view the full press release, visit https://ibn.fm/aY2Mk

About SS Innovations

SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery.  Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.  Visit the Company’s website at or for more information and updates.

NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.IBN.ai

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.ai/Disclaimer

The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

Corporate Communications

IBN
Austin, Texas
www.IBN.ai
512.354.7000 Office
[email protected]

In brief

SS Innovations International says surgeons completed a dual-console, beating-heart TECAB procedure at Medanta – The Medicity Hospital in Gurugram, India, using all five arms of its SSi Mantra robotic system. Dr. Nitin Kumar Rajput and Dr. Lalit Malik operated from separate consoles under the guidance of company Chairman and CEO Dr. Sudhir Srivastava. The company describes the operation as the first of its kind. It says the procedure used small incisions and did not require opening the chest or using a heart-lung machine, allowing the heart to keep beating. Medanta Chairman and Managing Director Dr. Naresh Trehan said the patient was doing extremely well afterward. SS Innovations characterized the procedure as an advancement in robotic cardiac surgery and linked it to its effort to broaden access to robotic surgery.

Key takeaways

  • SS Innovations says the procedure used both consoles and all five arms of its SSi Mantra system.
  • The surgery took place at Medanta – The Medicity Hospital in Gurugram, India.
  • The company says the operation was performed through small incisions without opening the chest or using a heart-lung machine.
  • Medanta’s chairman and managing director reported that the patient was doing extremely well after surgery.

SEC filings

Earlier from SS Innovations

  1. SS Innovations International (NASDAQ: SSII) CEO Outlines Growth Strategy as SSi Mantra Expands Robotic Surgery, Telesurgery, and Global Reach
  2. SS Innovations International (NASDAQ: SSII) Demonstrates Long-Distance Robotic Cardiac Surgery at Industry Events
  3. SS Innovations International (NASDAQ: SSII) Showcases Robotic Telesurgery Capabilities at International Medical Conferences 
  4. SS Innovations International (NASDAQ: SSII) Submits FDA Response for SSi Mantra Surgical Robotic System 
  5. SS Innovations International (NASDAQ: SSII) Builds Telerobotic Surgery Position as Remote Procedures Gain Ground
Back to News Center
EdgeNewswire

EdgeNewswire distributes your news to a targeted and established network of journalists and media outlets. We help build visibility and credibility for your organization and brand through trusted media coverage.

Copyright © 2024 - 2026   EdgeNewswire – Cutting Edge Press Release Distribution Services. All Rights Reserved.